Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

Additional Naloxone Formulation Submitted to FDA for Review

3 januari 2019

Monthly Prescribing Reference (MPR): Drugs in the Pipeline

wet- en regelgeving

Andexxa will go nationwide with FDA nod on Portola’s commercial production of the bleeding antidote

3 januari 2019

FiercePharma

wet- en regelgeving

Luye Pharma to submit NDA for Risperidone ER microspheres for injection with US FDA

2 januari 2019

Pharma Biz

wet- en regelgeving

PolarityTE seeks US FDA nod for OsteoTE, a human cellular and tissue─based product derived from patient's own bone

2 januari 2019

Pharma Biz

wet- en regelgeving

Edwards Lifesciences receives US FDA approval for SAPIEN 3 Ultra transcatheter heart valve

2 januari 2019

Pharma Biz

wet- en regelgeving

Ravicti Approved for Children Under 2 Months With Urea Cycle Disorders

31 december 2018

Monthly Prescribing Reference (MPR): Drug News

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer